Clinical Report: Exploring the Role of TMS in Evaluating Brain Function
Overview
This comprehensive review discusses the use of repetitive transcranial magnetic stimulation (rTMS) in treating mental disorders and evaluating brain function. It outlines the stimulation modes and parameter settings of TMS, summarizes the therapeutic effects of TMS on major mental disorders such as depression, bipolar disorder, and schizophrenia, and synthesizes the cellular and molecular mechanisms of its therapeutic effects based on preclinical research.
Background
The monoamine hypothesis has long been a focal point in understanding mental disorders, yet pharmacological treatments often yield unsatisfactory results. TMS, approved by the FDA for depression treatment in 2008, offers a non-invasive alternative for both therapeutic and diagnostic purposes.
Data Highlights
No numerical data provided in the source material.
Key Findings
TMS is used in treating major depressive disorder (MDD) and other mental disorders.
It can assess brain function by mapping neural pathways and measuring cortical excitability.
Therapeutic mechanisms involve neurotransmitter expression, neuroinflammation, and neuroplasticity.
Combining TMS with neuroimaging techniques enhances evaluation of treatment efficacy.
At least 50% of patients with depression do not respond to first-line antidepressants.
Clinical Implications
TMS can be utilized in treating patients with mental disorders who do not respond to conventional therapies.
Conclusion
TMS is a non-invasive approach to evaluate and treat mental health disorders.
